Left ventricular structure and function in prediabetic adults: Relationship with insulin resistance

Journal of Cardiovascular Disease Research

Volumn 2, Issue 1, 2011, Pages 23-28

  Sliem, Hamdy ^a   Nasr, Gamela ^a  

^a Suez Canal University Faculty of Medicine   (Egypt)

Author keywords

Insulin resistance; prediabetes; ventricular function

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE STRUCTURE; HEART LEFT VENTRICLE WALL; HEART VENTRICLE SEPTUM; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEFT VENTRICULAR DIASTOLIC FUNCTION; LEFT VENTRICULAR END DIASTOLIC DIAMETER; LEFT VENTRICULAR END SYSTOLIC DIAMETER; LEFT VENTRICULAR SYSTOLIC FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 79955079706     PISSN: 09753583     EISSN: 09762833     Source Type: Journal    
DOI: 10.4103/0975-3583.78583     Document Type: Article

References (36)

1. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-9. (Pubitemid 32893993)
2. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 1996;97:2601-10.
3. Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: A review. Diabetologia 2001;44:129-46. (Pubitemid 32156196)
4. Arcaro G, Cretti A, Balzano S. Insulin causes endothelial dysfunction in humans: Sites and mechanisms. Circulation 2002;105:576-82. (Pubitemid 34123431)
5. Dujardin KS, Tei C, Yeo TC, Hodge DO, Rossi A, Seward JB. New index of combined systolic and diastolic myocardial performance: A simple and reproducible measure of cardiac function-a study in normals and dilated cardiomyopathy. J Cardiol 1995;26:357-66. (Pubitemid 26011184)
6. Peterson LR, Waggoner AD, Schechtman KB, Meyer T, Gropler RJ, Barzilai B, et al. Alterations in left ventricular structure and function in young healthy obese women: Assessment by echocardiography and tissue Doppler imaging. J Am Coll Cardiol 2004;43:1399-404. (Pubitemid 38496345)
7. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Meigs JB, et al. Population-based incidence rates and risk factors for type 2 diabetes in white individuals: The Bruneck study. Diabetes 2004;53:1782-9. (Pubitemid 38857036)
8. Bonora E, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, et al. HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: Prospective data from the Verona Diabetes Complications Study. Diabetes Care 2002;25:1135-41. (Pubitemid 41071163)
9. Sunyer FX, Maggio Ca, Pi G. Obesity and type 2 diabetes, Endocrinol Metab. Clin North Am 2000;3:521-8.
10. Grundy SM. Multifactorial causation of obesity; Implications for prevention. Am J Clin Nutr 2003;67:563-72.
11. American Diabetes Association. Standard of medical care in diabetes-2008. Diabetes care 2008;31:S12-54.
12. Katz A, Nambi S, Mather K, Baron A, Follmann D, Sullivan G, et al. Quantitative insulin sensitivity check index: A simple accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2004;85:2402-12.
13. Abraham P, Laskowski C, Zhan WZ. Myocardial contractility by strain echocardiography: Comparison with physiological measurements in an in vitro model, Am J Physiol 2003;285:2599-604.
14. Heatlie GJ, Giles M. Echocardiography and the general physician. Postgrad. Med J 2004;80:84-8.
15. Saul G, Myerson L. Left Ventricular Mass: Reliability of M-Mode and 2-Dimensional Echocardiographic Formulas. Hypertension 2002;40:673-8.
16. Raev DC. Which left ventricular function is impaired earlier in the evolution of diabetic cardiomyopathy? An echocardiographic study of young type I diabetic patients. Diabetes Care 1994;17:633-9. (Pubitemid 24198025)
17. Zabalgoitia M, Ismaeil MF, Anderson L, Maklady FA. Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well controlled type 2 diabetes mellitus. Am J Cardiol 2001;87:320-3. (Pubitemid 32144874)
18. Stahrenberg R, Edelmann F, Mende M, Kockskamper A, Dungen HD, Scherer M, et al. Association of glucose metabolism with diastolic function along the diabetic continuum. Diabetologia 2010;53:1331-40.
19. Zoungas S, de Galan BE, Ninomiya T, Grobbee D, Hamet P, Heller S, et al. Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial. Diabetes Care 2009;32:2068-74.
20. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-72. (Pubitemid 351831357)
21. Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-59. (Pubitemid 351831356)
22. ACCORD Study Group. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med 2010. DOI: 10.1056/ NEJMoa1001288. Available from: http://www.nejm.org. [Last accessed on 2010 June 30].
23. Dinh W, Lankisch M, Nickl W, Scheyer D, Scheffold T, Kramer F, et al. Insulin resistance and glycemic abnormalities are associated with deterioration of left ventricular diastolic function: A cross-sectional study. Cardiovasc Diabetol 2010;9:63.
24. Peterson LR, Waggoner AD, Schechtman KB, Meyer T, Gropler RJ, Barzilai B, et al. Alterations in left ventricular structure and function in young healthy obese women: Assessment by echocardiography and tissue Doppler imaging. J Am Coll Cardiol 2004;43:1399-404. (Pubitemid 38496345)
25. de Simone G, Palmieri V, Bella JN, Celentano A, Hong Y, Oberman A, et al. Association of left ventricular hypertrophy with metabolic risk factors. J Hypertens 2002;20:323-31. (Pubitemid 34913799)
26. From AM, Scott Cg, Chen Hm. The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a populationbased study. J AM Coll Cardiol 2010;55:300-5.
27. Cozma A, Orã°an O, Sâmpelean D, Fodor A, Vlad C, Negrean V, et al. Endothelial dysfunction in metabolic syndrome. Rom J Intern Med 2009;47:133-40.
28. Arcaro G, Cretti A, Balzano S. Insulin causes endothelial dysfunction in humans: Sites and mechanisms. Circulation 2000;105:576-82.
29. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 1996;97:2601-10.
30. Dwyer EM, Asif M, Ippolito T, Gillespie M. Role of hypertension, diabetes, obesity, and race in the development of symptomatic myocardial dysfunction in a predominantly minority population with normal coronary arteries. Am Heart J 2000;139:297-304. (Pubitemid 30090807)
31. Visser M, Bouter L, McQuillan G, Wener M, Harris T. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999;282:2131-5.
32. Marefella R, Siniscalchi M, Esposito K, Sellito A, Romano C. Effects of stress hyperglycemia on acute myocardial infarction. Diabetes Care 2003;26:3129-35.
33. Okamoto Y, Arita Y, Nishida M, Muraguchi M, Ouchi N, Takahashi M. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res 2000;32:47-50. (Pubitemid 30143606)
34. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004;24:29-33. (Pubitemid 38082408)
35. Ballo P, Cameli M, Mondillo S, Giacomin E, Lisi M, Padeletti M, et al. Impact of diabetes and hypertension on left ventricular longitudinal systolic function. Diabetes Res Clin Pract 2010;90:209-15.
36. de las Fuentes L, Brown AL, Mathews SJ, Waggoner AD, Soto PF, Gropler RJ, et al. Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass. Eur Heart J 2007;28:553-9. (Pubitemid 47355514)